IAVI’s goal is to enhance data accessibility for scientific research in the area of HIV vaccine development. This is one of the core principle that guides all IAVI’s work. The IAVI DataSpace provides a platform for making this aim a reality. The ultimate vision is to grow the IAVI DataSpace by populating it with secondary data sets resulting from data derived from a wide range of IAVI-administered clinical trials. This will facilitate data-driven science and accelerate innovative research in the field of infectious disease prevention and cure.
We have put together a proportionate governance to ensure the IAVI DataSpace operates for the benefit of all within exiting regulatory frameworks. This covers data storage, access and use. All accessible data have been de-identified and pseudo-anonymised. New data resulting from work conducted with data obtained from the warehouse need to be deposited into the IAVI DataSpace and are subject to similar rules as existing data. All data requests will be managed by IAVI and will be assessed using the following criteria:
- The scientific value of the research proposal using the data
- The proposed research can be reasonably addressed using the requested data and research methodology
- Competence of the investigators
Scientific review by peer experts may be required if IAVI is unable to verify the scientific merit of the proposal.
Applicants will need to agree to the terms of the IAVI Data User Application and Agreement which must be completed and submitted with all data requests.
IAVI follows the funder’s Open Data Policy, in particular USAID’s open data policy ADS 579 – USAID Development Data.